MaxCyte, Inc. (MXCT)
1.35
+0.04
(+3.05%)
USD |
NASDAQ |
Nov 06, 10:20
MaxCyte Enterprise Value : 50.60M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 50.60M |
| November 04, 2026 | 59.09M |
| November 03, 2026 | 66.52M |
| November 02, 2026 | 65.46M |
| October 30, 2026 | 80.31M |
| October 29, 2026 | 95.17M |
| October 28, 2026 | 93.05M |
| October 27, 2026 | 75.01M |
| October 26, 2026 | 71.82M |
| October 23, 2026 | 60.15M |
| October 22, 2026 | 63.33M |
| October 21, 2026 | 67.58M |
| October 20, 2026 | 63.33M |
| October 19, 2026 | 49.54M |
| October 16, 2026 | 49.54M |
| October 15, 2026 | 49.54M |
| October 14, 2026 | 44.23M |
| October 13, 2026 | 13.91M |
| October 12, 2026 | 17.16M |
| October 09, 2026 | 18.76M |
| October 08, 2026 | 19.82M |
| October 07, 2026 | 21.94M |
| October 06, 2026 | 27.25M |
| October 05, 2026 | 26.19M |
| October 02, 2026 | 25.12M |
| Date | Value |
|---|---|
| October 01, 2026 | 27.25M |
| September 30, 2026 | 30.43M |
| September 29, 2026 | 36.80M |
| September 28, 2026 | 34.68M |
| September 25, 2026 | 35.74M |
| September 24, 2026 | 37.86M |
| September 23, 2026 | 37.86M |
| September 22, 2026 | 43.17M |
| September 21, 2026 | 41.04M |
| September 18, 2026 | 37.86M |
| September 17, 2026 | 38.39M |
| September 16, 2026 | 36.80M |
| September 15, 2026 | 37.86M |
| September 14, 2026 | 36.27M |
| September 11, 2026 | 34.68M |
| September 10, 2026 | 37.86M |
| September 09, 2026 | 41.04M |
| September 08, 2026 | 46.88M |
| September 04, 2026 | 47.41M |
| September 03, 2026 | 45.29M |
| September 02, 2026 | 46.35M |
| September 01, 2026 | 43.17M |
| August 31, 2026 | 48.47M |
| August 28, 2026 | 41.04M |
| August 27, 2026 | 47.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.63B |
| Bio-Rad Laboratories, Inc. | 9.617B |
| Bruker Corp. | 10.48B |
| Azenta, Inc. | 1.362B |
| Danaher Corp. | 181.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.874M |
| Revenue (Quarterly) | 7.271M |
| Total Expenses (Quarterly) | 16.14M |
| EPS Diluted (Quarterly) | -0.0831 |
| Gross Profit Margin (Quarterly) | 63.86% |
| Profit Margin (Quarterly) | -122.0% |
| Earnings Yield | -24.73% |
| Normalized Earnings Yield | -20.08 |